Cite

HARVARD Citation

    Sokolova, A. et al. (2021). Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations. Prostate. 81 (16), pp. 1382-1389. [Online]. 
  
Back to record